Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

Inclusion Criteria 1. Signed Informed Consent Form, prior to screening evaluations 2. In good physical and mental health 3. Pre-menopausal females between the ages of 21-37 years (both inclusive) at the time of randomisation 4. Infertility for at least 1 year before randomisation, except for proven bilateral tubal infertility Exclusion Criteria 1. Any clinically significant systemic disease 2. Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney) 3. History of recurrent miscarriage 4. Undiagnosed vaginal bleeding